BroadOak Capital Partners
Kyle Wilson is a Partner at BroadOak Capital Partners, a privately held investment bank focused on the life sciences industry since March 2011. Additionally, Kyle serves on the Advisory Board of Slone Partners and was a Board Member at Techcyte until April 2023. Previously, Kyle held the position of Business Advisory Member at Cenetron Diagnostics from March 2012 to July 2019, and worked as a Principal at Canaccord Genuity from February 2004 to March 2011. Early career roles include Vice President at RBC Capital Markets and Associate at Morgan Keegan. Kyle holds an MBA and a JD from the University of Oklahoma, as well as a BBA in Finance from the same institution.
This person is not in the org chart
BroadOak Capital Partners
BroadOak Capital Partners, with headquarters in Washington, DC, and San Francisco, is a life-sciences focused boutique financial institution that provides direct investment and investment banking services to companies in research tools and consumables, diagnostics, biopharma services, and adjacent markets. BroadOak has led or participated in investments in more than fifty companies across multiple funds and investment vehicles.